Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

IMCR

Immunocore Holdings plc ADR

May 02 • 03:21PM ET

59.47

Dollar change +0.42
Percentage change 0.71	%

Healthcare • Biotechnology • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.14	Insider Own	1.91%	Shs Outstand	49.73M	Perf Week	2.53%
Market Cap	2.96B	Forward P/E	-	EPS next Y	-2.37	Insider Trans	-11.94%	Shs Float	48.78M	Perf Month	-6.71%
Income	-55.40M	PEG	-	EPS next Q	-0.37	Inst Own	74.14%	Short Float	8.38%	Perf Quarter	-20.93%
Sales	249.84M	P/S	11.84	EPS this Y	-47.31%	Inst Trans	23.68%	Short Ratio	10.01	Perf Half Y	33.94%
Book/sh	7.37	P/B	8.06	EPS next Y	-42.43%	ROA	-9.89%	Short Interest	4.09M	Perf Year	3.28%
Cash/sh	8.90	P/C	6.68	EPS next 5Y	-	ROE	-15.74%	52W Range	42.21 - 76.98	Perf YTD	-12.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-12.27%	52W High	-22.75%	Beta	0.92
Dividend TTM	-	Quick Ratio	3.77	Sales past 5Y	88.61%	Gross Margin	99.46%	52W Low	40.89%	ATR (14)	2.35
Dividend Ex-Date	-	Current Ratio	3.80	EPS Y/Y TTM	-0.80%	Oper. Margin	-23.66%	RSI (14)	51.14	Volatility	3.83% 4.20%
Employees	497	Debt/Eq	0.23	Sales Y/Y TTM	42.70%	Profit Margin	-22.17%	Recom	1.28	Target Price	84.41
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	34.63%	Payout	-	Rel Volume	0.75	Prev Close	59.05
Sales Surprise	5.37%	EPS Surprise	-61.42%	Sales Q/Q	25.54%	Earnings	Feb 28 BMO	Avg Volume	408.62K	Price	59.47
SMA20	2.81%	SMA50	-3.74%	SMA200	-0.12%	Trades		Volume	277,785	Change	0.71%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-24	Initiated	Leerink Partners	Outperform	$74
Nov-20-23	Resumed	JP Morgan	Overweight	$60
Nov-02-23	Initiated	Cantor Fitzgerald	Overweight
Oct-31-23	Initiated	Robert W. Baird	Outperform	$84
Sep-13-23	Upgrade	JP Morgan	Neutral → Overweight	$9 → $22
Sep-13-23	Initiated	Needham	Buy	$75
Aug-16-23	Initiated	CapitalOne	Overweight	$84
Jul-17-23	Initiated	Canaccord Genuity	Hold	$67
Mar-31-23	Initiated	Mizuho	Buy	$70
Mar-30-23	Initiated	Guggenheim	Buy	$85
Mar-24-23	Initiated	Bryan Garnier	Buy	$16
Dec-16-22	Upgrade	Goldman	Neutral → Buy	$33 → $80
Nov-30-22	Initiated	Barclays	Overweight	$80
Sep-09-22	Initiated	Morgan Stanley	Overweight	$77
Sep-08-22	Initiated	Ladenburg Thalmann	Buy	$82
Aug-08-22	Initiated	Cowen	Outperform	$70
Aug-02-22	Initiated	BTIG Research	Buy	$85
Feb-08-22	Initiated	H.C. Wainwright	Buy	$80
Oct-20-21	Initiated	Oppenheimer	Outperform	$56
Mar-02-21	Initiated	JP Morgan	Overweight	$58

Show Previous Ratings

Apr-29-24 07:15AM	Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target (MT Newswires)
Apr-24-24 10:00AM	Immunocore announces upcoming presentation and posters at ASCO 2024 (GlobeNewswire)
Apr-04-24 04:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Mar-13-24 11:07AM	Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio (InvestorPlace)
Mar-05-24 04:30PM	Immunocore presented two posters at CROI 2024 (GlobeNewswire)
07:00AM	Loading…
Mar-01-24 07:00AM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Feb-29-24 10:51AM	Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 04:53PM	Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ... (GuruFocus.com)
07:34AM	Immunocore reports fourth quarter and full year 2023 financial results and provides a business update (GlobeNewswire)
Feb-22-24 07:00AM	Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial (GlobeNewswire)
Feb-21-24 07:00AM	Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 (GlobeNewswire)
Feb-01-24 09:00AM	DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay (PR Newswire)
05:16AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last? (Zacks)
Jan-30-24 11:30PM	Immunocore Prices Upsized Convertible Senior Notes Offering (GlobeNewswire) -6.19%
Jan-29-24 04:05PM	Immunocore Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
09:55AM	Loading…
Jan-10-24 09:55AM	Should You Buy Immunocore Holdings PLC Sponsored ADR (IMCR) After Golden Cross? (Zacks)
Jan-09-24 01:51PM	Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets. (Barrons.com) +5.95%
Jan-05-24 07:00AM	Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation (GlobeNewswire)
Jan-03-24 07:00AM	Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 12:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-13-23 09:55AM	How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32% (Zacks)
Nov-30-23 04:00AM	Levicept Appoints Eliot Forster as CEO (GlobeNewswire) +6.83%
Nov-27-23 09:55AM	Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect? (Zacks)
Nov-20-23 09:55AM	Bears are Losing Control Over Immunocore Holdings PLC Sponsored ADR (IMCR), Here's Why It's a 'Buy' Now (Zacks)
Nov-14-23 09:09AM	11 Best Undervalued UK Stocks To Buy Now (Insider Monkey)
Nov-10-23 09:55AM	Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High? (Zacks)
Nov-07-23 07:00AM	Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +5.71%
Nov-01-23 04:01PM	Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023 (GlobeNewswire)
Oct-30-23 04:30PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Oct-21-23 08:45AM	Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial (GlobeNewswire)
09:55AM	Loading…
Oct-19-23 09:55AM	Wall Street Analysts See a 60.86% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High? (Zacks)
Oct-07-23 03:33PM	12 Stock Picks From Our Healthcare Roundtable Pros. Weight Loss Isnt the Only Big Deal in Medicine. (Barrons.com)
Oct-06-23 07:01AM	Immunocore announces upcoming presentation and posters at ESMO 2023 (GlobeNewswire)
Sep-22-23 06:40PM	Cardlytics, Immunocore, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-14-23 02:02PM	10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts (Insider Monkey)
Sep-11-23 05:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Sep-01-23 04:00PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Aug-13-23 07:15AM	Immunocore Holdings plc (NASDAQ:IMCR) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 10:22PM	Q2 2023 Immunocore Holdings PLC Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-08-23 08:48AM	Why Earnings Season Could Be Great for Immunocore (IMCR) (Zacks)
Aug-03-23 08:00AM	Immunocore to report second quarter 2023 financial results and host call on August 10, 2023 (GlobeNewswire)
Jul-18-23 06:05AM	Immunocore Holdings (NASDAQ:IMCR) shareholders have earned a 41% return over the last year (Simply Wall St.)
Jun-07-23 06:59AM	With 45% stake, Immunocore Holdings plc (NASDAQ:IMCR) seems to have captured institutional investors' interest (Simply Wall St.)
Jun-03-23 07:00AM	Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO (GlobeNewswire)
Jun-01-23 04:30PM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
May-17-23 01:18AM	Why companies dont want to list in the UK any more (Financial Times)
May-11-23 06:00AM	Immunocore Holdings First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-10-23 07:00AM	Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-03-23 04:30PM	Immunocore to present at the Bank of America Securities 2023 Health Care Conference (GlobeNewswire)
Apr-24-23 01:00AM	Capitalism without the capital (Financial Times)
Apr-19-23 12:00AM	Britains capitalism without capital: the pension funds that shun risk (Financial Times)
Apr-18-23 07:00AM	Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival (GlobeNewswire)
07:00AM	Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023 (PR Newswire)
Apr-17-23 08:32AM	Immunocore Holdings plc's (NASDAQ:IMCR) Share Price Not Quite Adding Up (Simply Wall St.)
Apr-11-23 07:00AM	Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-05-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
Mar-30-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:00AM	Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-28-23 03:57PM	Top 10 Growth Stocks in Biotech (Insider Monkey)
Mar-24-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know (Zacks)
Mar-16-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Gains But Lags Market: What You Should Know (Zacks)
09:00AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-14-23 04:30PM	Immunocore to present four posters at AACR Annual Meeting 2023 (GlobeNewswire)
Mar-03-23 10:55AM	Immunocore Holdings plc (NASDAQ:IMCR) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 11:32PM	Q4 2022 Immunocore Holdings PLC Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Immunocore Reports 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-23 08:30AM	Is a Surprise Coming for Immunocore (IMCR) This Earnings Season? (Zacks)
07:00AM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Feb-27-23 01:47PM	Immunocore (IMCR) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-24-23 09:00AM	Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to Know (Zacks)
Feb-23-23 07:00AM	Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023 (GlobeNewswire)
Feb-22-23 05:50PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
01:32PM	Immunocore Reveals First Data From HIV Infection Candidate Study (Benzinga)
07:00AM	Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV (GlobeNewswire)
Feb-15-23 05:50PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-14-23 06:57AM	Immunocore Holdings plc's (NASDAQ:IMCR) Path To Profitability (Simply Wall St.)
05:40AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains? (Zacks)
Feb-13-23 05:35PM	Biotech's Drug Pipeline Expands From Melanoma To Other Cancers (Investor's Business Daily) +6.45%
Feb-08-23 05:50PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
Feb-03-23 02:58PM	IPO Stock Of The Week: Biotech Leader Immunocore Approaches Latest Buy Point (Investor's Business Daily)
Feb-02-23 05:50PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-01-23 09:00AM	Here is What to Know Beyond Why Immunocore Holdings PLC Sponsored ADR (IMCR) is a Trending Stock (Zacks)
07:00AM	Immunocore to present at upcoming investor conferences (GlobeNewswire)
Jan-30-23 10:20AM	3 Pharma Stocks That Will Mint Millionaires (InvestorPlace)
Jan-27-23 05:50PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Gains But Lags Market: What You Should Know (Zacks)
Jan-25-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
Jan-20-23 01:34PM	IPO Stock Of The Week: Biotech Leader Immunocore Shows New Buy Point (Investor's Business Daily)
Jan-19-23 06:00PM	Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know (Zacks)
09:40AM	Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-18-23 06:50AM	Immunocore Holdings (NASDAQ:IMCR) rises 8.5% this week, taking one-year gains to 204% (Simply Wall St.)
Jan-13-23 04:41AM	Immunocore Holdings PLC Sponsored ADR (IMCR) Soars 6.9%: Is Further Upside Left in the Stock? (Zacks)
Jan-11-23 08:02AM	Heska (HSKA) Moves 9.0% Higher: Will This Strength Last? (Zacks)
Jan-09-23 07:00AM	Immunocore announces strategic priorities including pipeline expansion for 2023 -2024 (GlobeNewswire) -5.74%
Jan-06-23 06:35PM	Envestnet and Dave & Busters Stock See Action From Activist Investors (Barrons.com)
Jan-04-23 07:00AM	Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-30-22 10:00AM	Best Momentum Stocks to Buy for December 30th (Zacks)
Dec-28-22 07:15AM	Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals (Zacks)
Dec-27-22 11:21AM	4 Top Biotech Stocks Worth Adding to Your Portfolio in 2023 (Zacks)
Dec-22-22 10:53AM	The Zacks Analyst Blog Highlights United Therapeutics, Intra-Cellular Therapies, Immunocore Holdings and Eli Lilly (Zacks)

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX - Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
St Leger Tina Amber	CHIEF HR OFFICER	Apr 01 '24	Option Exercise	29.87	4,375	130,681	4,375	Apr 03 04:15 PM
St Leger Tina Amber	CHIEF HR OFFICER	Apr 01 '24	Sale	64.06	4,375	280,262	0	Apr 03 04:15 PM
Berman David M	HEAD OF R&D	Feb 28 '24	Option Exercise	17.46	36,509	637,447	36,509	Mar 01 04:15 PM
Berman David M	HEAD OF R&D	Feb 28 '24	Sale	68.59	36,509	2,504,158	0	Mar 01 04:15 PM
Berman David M	HEAD OF R&D	Feb 27 '24	Option Exercise	17.46	54,938	959,217	54,938	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 27 '24	Sale	70.86	54,938	3,893,030	0	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 26 '24	Option Exercise	17.46	28,553	498,535	28,553	Feb 28 04:15 PM
Berman David M	HEAD OF R&D	Feb 26 '24	Sale	70.65	28,553	2,017,288	0	Feb 28 04:15 PM
St Leger Tina Amber	Chief HR Officer	Jan 03 '24	Option Exercise	29.87	4,375	130,681	4,375	Jan 05 04:17 PM
St Leger Tina Amber	Chief HR Officer	Jan 03 '24	Sale	69.89	4,375	305,781	0	Jan 05 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IMCR

Immunocore Holdings plc ADR

Upgrade your FINVIZ experience